Filing Details

Accession Number:
0001415889-25-019380
Form Type:
4
Zero Holdings:
No
Publication Time:
2025-07-03 19:48:00
Reporting Period:
2025-07-01
Filing Date:
2025-07-03
Accepted Time:
2025-07-03 19:48:00
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1699382 Pmv Pharmaceuticals Inc. PMVP () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1341642 Henry David Mack C/O Pmv Pharmaceuticals, Inc.
400 Alexander Park Drive, Suite 301
Princeton NJ 08540
President And Ceo No No No No
Transaction Summary
Sold: 58,411 shares Avg. Price: $1.06 Total Value: $62,178.51
Number of Shares After Transactions: 536,133 shares
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2025-07-01 58,411 $1.06 536,133 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 165,307 Indirect See footnote
Common Stock 147,915 Indirect See footnote
Common Stock 56,978 Indirect See footnote
Footnotes
  1. The reported shares were sold to satisfy the reporting person's tax obligations in connection with the vesting of restricted stock units, or RSUs.
  2. Includes 15,528 shares acquired under the Issuer's Employee Stock Purchase Plan on May 15, 2025.
  3. The shares are held of record by the Stinson 2021 Irrevocable Trust. The reporting person disclaims beneficial ownership of these securities except to the extent of any pecuniary interest therein.
  4. The shares are held of record by the Mack-Mulligan Revocable Trust. The reporting person disclaims beneficial ownership of these securities except to the extent of any pecuniary interest therein.
  5. The shares are held of record by the Mack/Mulligan 2020 Irrevocable Descendants' Trust. The reporting person disclaims beneficial ownership of these securities except to the extent of any pecuniary interest therein.